Category Novartis

Tourmaline Bio surges after Novartis $1.4 billion acquisition; analysts see strong fit
Shares of Tourmaline Bio surged in premarket trading on Tuesday after the US-based biotechnology company agreed to be acquired by Swiss pharmaceuti...
Sep, 09, 2025
2 min read
by Invezz